Advertising of medicines

Master the intricate regulations surrounding the promotion of medicines, ensuring compliance while maximising marketing effectiveness. Gain practical insights on balancing creative advertising strategies with stringent legal requirements in the life sciences sector. Arm yourself with essential guidance to navigate this highly regulated field, maintaining ethical and lawful promotional practices.

View Life Sciences by content type:

Latest Life Sciences News

Advocate General’s Opinion on whether excipients are active ingredients under the SPC Regulation (Halozyme, Inc v Czech IPO CJEU Case C-456/24)

Life Science analysis: The Advocate General has opined that, for the purposes of Regulation (EC) No 469/2009(the EU SPC Regulation), the...

MHRA publishes findings and research to inform future AI healthcare regulation

The Medicines and Healthcare products Regulatory Agency (MHRA) has published two reports relating to the National Commission into the Regulation of...

Irish Presidency of Council of the EU publishes programme for July to December 2026

The Irish Presidency of the Council of the EU has published its programme for 1 July 2026 to 31 December 2026, outlining its priorities and direction....

DHSC publishes consultation outcome on statutory scheme headline payment percentage for branded medicines

The Department of Health and Social Care (DHSC) has published its response to consultation on changes to the statutory scheme controlling the cost of...

Featured Life Sciences content

Introduction to technology transfer agreements in the Life Sciences industry

Introduction to technology transfer agreements in the Life Sciences industryWhat is a technology transfer agreement?The term ‘technology transfer...

Regulation of cosmetic products in the UK

Regulation of cosmetic products in the UKThis Practice Note provides an overview of the UK regulatory framework for cosmetics. It sets out the legal...

Intellectual property protection for medical devices

Intellectual property protection for medical devicesChanges to intellectual property (IP) law from 1 January 2021Before discussing how intellectual...

Second and subsequent medical use patent claims

Second and subsequent medical use patent claimsBackground to medical use claimsSecond (and subsequent) medical use patent claims are specific to the...

Practice notes

The experimental use and Bolar-type exemptions to patent infringement

The experimental use and Bolar-type exemptions to patent infringementPatent systems are intended to foster innovation, not to impede it. For this...

Read More >

Produced in partnership with Charlie French of Bristows and Milly Wickson of Bristows

13th Oct

In-house

News

The 2024 ABPI Code of Practice—what are the key proposed changes?

The PMCPA has recently launched a consultation to update:•the 2021 ABPI Code of Practice•the Constitution and Procedure which sets out how the PMCPA...

Read More >

3rd Jun

News

MHRA releases guidance on pharmacovigilance following Windsor Framework agreement

The Medicines and Healthcare products Regulatory Agency (MHRA) has released guidance on the implementation of changes to pharmacovigilance for...

Read More >

3rd Jun

Practice notes

The regulation of medical devices in the UK

The regulation of medical devices in the UKThis Practice Note provides an overview of the UK regulatory regime for medical devices. It explains the...

Read More >

30th May

Brexit